Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A

J Aramburu1, M B Yaffe, C López-Rodríguez

  • 1Department of Pathology, Harvard Medical School, Boston, MA 02115, USA.

Science (New York, N.Y.)
|September 25, 1999
PubMed